(2R,3R,8R,9R,10R,13R,14S,17Z)-3-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-17-[(6R)-6-methyl-3-oxo-7-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-ylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-16-one

Details

Top
Internal ID b344c285-eace-4b0d-9c7d-5c38987d97a0
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name (2R,3R,8R,9R,10R,13R,14S,17Z)-3-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-17-[(6R)-6-methyl-3-oxo-7-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-ylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-16-one
SMILES (Canonical) CC(CCC(=O)C(=C1C(=O)CC2C1(CCC3C2CC=C4C3(CC(C(C4)OC5C(C(C(C(O5)CO)OC6C(C(C(C(O6)CO)O)OC7C(C(C(CO7)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)C)C)C)COC1C(C(C(C(O1)CO)O)O)O
SMILES (Isomeric) C[C@H](CCC(=O)/C(=C/1\C(=O)C[C@@H]2[C@]1(CC[C@@H]3[C@H]2CC=C4[C@@]3(C[C@H]([C@@H](C4)O[C@@H]5[C@H]([C@@H]([C@H]([C@@H](O5)CO)O[C@@H]6[C@H]([C@@H]([C@H]([C@@H](O6)CO)O)O[C@@H]7[C@H]([C@@H]([C@H](CO7)O)O)O)O[C@@H]8[C@H]([C@@H]([C@H]([C@@H](O8)CO)O)O[C@@H]9[C@H]([C@@H]([C@H]([C@@H](O9)CO)O)O)O)O)O)O)O)C)C)/C)CO[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O
InChI InChI=1S/C62H98O34/c1-21(19-85-55-47(81)43(77)39(73)32(14-63)88-55)5-8-27(68)22(2)37-28(69)12-26-24-7-6-23-11-31(29(70)13-62(23,4)25(24)9-10-61(26,37)3)87-57-49(83)45(79)51(36(18-67)92-57)93-60-54(53(42(76)35(17-66)91-60)95-56-46(80)38(72)30(71)20-86-56)96-59-50(84)52(41(75)34(16-65)90-59)94-58-48(82)44(78)40(74)33(15-64)89-58/h6,21,24-26,29-36,38-60,63-67,70-84H,5,7-20H2,1-4H3/b37-22+/t21-,24-,25-,26+,29-,30+,31-,32+,33+,34+,35+,36+,38-,39+,40+,41+,42+,43-,44-,45+,46+,47+,48+,49+,50+,51+,52-,53-,54+,55+,56-,57+,58-,59-,60-,61-,62+/m1/s1
InChI Key PIACQCAHKHMXIA-JUFOWFPSSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C62H98O34
Molecular Weight 1387.40 g/mol
Exact Mass 1386.5939502 g/mol
Topological Polar Surface Area (TPSA) 550.00 Ų
XlogP -7.20
Atomic LogP (AlogP) -8.66
H-Bond Acceptor 34
H-Bond Donor 20
Rotatable Bonds 22

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,8R,9R,10R,13R,14S,17Z)-3-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-17-[(6R)-6-methyl-3-oxo-7-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-ylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-16-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7521 75.21%
Caco-2 - 0.8636 86.36%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.8375 83.75%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8395 83.95%
OATP1B3 inhibitior + 0.8381 83.81%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.5798 57.98%
BSEP inhibitior + 0.9698 96.98%
P-glycoprotein inhibitior + 0.7433 74.33%
P-glycoprotein substrate + 0.7057 70.57%
CYP3A4 substrate + 0.7513 75.13%
CYP2C9 substrate - 0.7956 79.56%
CYP2D6 substrate - 0.8844 88.44%
CYP3A4 inhibition - 0.8852 88.52%
CYP2C9 inhibition - 0.9245 92.45%
CYP2C19 inhibition - 0.9426 94.26%
CYP2D6 inhibition - 0.9538 95.38%
CYP1A2 inhibition - 0.9246 92.46%
CYP2C8 inhibition + 0.7077 70.77%
CYP inhibitory promiscuity - 0.9675 96.75%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5863 58.63%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.8982 89.82%
Skin irritation + 0.5512 55.12%
Skin corrosion - 0.9411 94.11%
Ames mutagenesis - 0.7432 74.32%
Human Ether-a-go-go-Related Gene inhibition + 0.8099 80.99%
Micronuclear - 0.7800 78.00%
Hepatotoxicity - 0.7500 75.00%
skin sensitisation - 0.9342 93.42%
Respiratory toxicity + 0.6889 68.89%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity - 0.8219 82.19%
Acute Oral Toxicity (c) III 0.5383 53.83%
Estrogen receptor binding + 0.8001 80.01%
Androgen receptor binding + 0.7505 75.05%
Thyroid receptor binding + 0.5961 59.61%
Glucocorticoid receptor binding + 0.7427 74.27%
Aromatase binding + 0.6753 67.53%
PPAR gamma + 0.8115 81.15%
Honey bee toxicity - 0.5945 59.45%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity + 0.9503 95.03%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.32% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.84% 96.09%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 96.03% 91.24%
CHEMBL2581 P07339 Cathepsin D 95.75% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.86% 94.45%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.52% 97.25%
CHEMBL5255 O00206 Toll-like receptor 4 92.28% 92.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.90% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.30% 97.09%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 88.60% 90.71%
CHEMBL3359 P21462 Formyl peptide receptor 1 88.39% 93.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.24% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.14% 89.00%
CHEMBL226 P30542 Adenosine A1 receptor 88.01% 95.93%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.21% 95.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 86.01% 95.89%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 85.81% 96.77%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 85.14% 96.00%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 84.81% 93.04%
CHEMBL2842 P42345 Serine/threonine-protein kinase mTOR 84.44% 92.78%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.41% 95.89%
CHEMBL218 P21554 Cannabinoid CB1 receptor 83.79% 96.61%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 83.69% 95.71%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 83.11% 94.33%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 82.49% 97.14%
CHEMBL1937 Q92769 Histone deacetylase 2 81.55% 94.75%
CHEMBL340 P08684 Cytochrome P450 3A4 81.54% 91.19%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 80.70% 96.90%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 80.37% 92.88%
CHEMBL3922 P50579 Methionine aminopeptidase 2 80.33% 97.28%
CHEMBL3060 Q9Y345 Glycine transporter 2 80.19% 99.17%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Cestrum nocturnum

Cross-Links

Top
PubChem 162851684
LOTUS LTS0188080
wikiData Q105209361